Medical News

RSS

Dr. Reddy's Laboratories files Annual Report on Form 20-F

Dr. Reddy's Laboratories Limited today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2010 was filed with the United States Securities and Exchange Commission.

23 Sep 2010

Covidien launches Puritan Bennett 560 ventilator in Europe

Covidien, a leading global healthcare products company and recognized innovator in mechanical ventilation and respiratory care devices, today announced that the Puritan Bennett™ 560 ventilator is now available in Europe. The Puritan Bennett 560 ventilator is compact and portable, weighing just 4.5 kg. This lightweight device provides mobile respiratory support, enabling ventilated adult and pediatric patients to pursue regular activities with peace of mind.

23 Sep 2010

FDA approves fingolimod drug for multiple sclerosis

The first oral medication for multiple sclerosis was approved today by the Food & Drug Administration. Physicians praised the decision to approve the drug, called fingolimod, saying it would give multiple sclerosis patients new options for treatment.

23 Sep 2010

Masonic Cancer Center receives five-year program project research grants from NCI

Two of the University of Minnesota Masonic Cancer Center's leading physician-scientists on research and treatment of cancers of the blood and bone marrow Philip McGlave, M.D., and Jeffrey Miller, M.D., have received renewed five-year program project research grants totaling almost $26 million from the National Cancer Institute (NCI).

23 Sep 2010

Scientists identify genetic variants that increase asthma susceptibility

An international study looking at DNA from over 26,000 people has identified several genetic variants that substantially increase susceptibility to asthma in the population. The findings, published in the New England Journal of Medicine, will help scientists to focus their efforts to develop better therapies for the illness.

23 Sep 2010

Portable laser devices to probe early signs of diseases

Portable devices that use a laser beam to probe bones, teeth, and other parts of the body for early signs of diseases like osteoporosis and tooth decay may seem like something out of science fiction. But those devices are moving closer to reality, according to an article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

23 Sep 2010

People's Care ranks #2140 on Inc. 5000 list of fastest growing private companies

Inc. Magazine included Southern California-based People's Care in its fourth annual Inc. 5000, an exclusive ranking of the country's fastest growing private companies. The list represents a comprehensive look at an important segment of the United States' economy: independent entrepreneurs. People's Care joins other prominent brands on the list, including music website Pandora, 7-Eleven and Radio Flyer.

23 Sep 2010

Genomic imprinting can influence carrier's selfish or altruistic behavior

If you are more inclined to love thyself than thy neighbor, it could be your mother's fault. Those are the findings of Francisco -beda, assistant professor of ecology and evolutionary biology at the University of Tennessee, Knoxville.-beda, along with fellow evolutionary biologist Andy Gardner from Oxford University, examined the impact that genomic imprinting has on the carrier's selfish or altruistic behavior.

23 Sep 2010

Opinions: Genetically-modified crops can improve vaccines; MDG focus on women and girls; U.S. leadership for MDGs; Boosting access to drugs; Merits of bilateral development assistance

"The U.N. estimates that diarrheal diseases kill 1.8 million people every year. … So you might take it as good news that American company Ventria Bioscience says it has hit on an improvement to existing rehydration therapies, which could mean another tool in the fight against diarrhea," according to a Wall Street Journal editorial examining the delays the company has experienced since it first sought to have its product approved by the FDA back in 2004, even "[a]fter a panel of food, medicine, immunology, child nutrition and health experts had declared its product safe."

23 Sep 2010

First intestine transplant in Michigan performed on 50-year-old Port Austin patient

The first intestine (bowel) transplant in Michigan was performed on a 50-year-old patient from Port Austin by physicians at Henry Ford Hospital.

23 Sep 2010

CSI to present CALCIUM 360° Study results at TCT symposium

Cardiovascular Systems, Inc., announced today that its CALCIUM 360° Study, the first-of-its kind prospective, randomized feasibility study, demonstrated the safety and effectiveness of plaque modification with the Diamondback 360 PAD System versus the standard of care treatment (balloon angioplasty) in below-the-knee arteries.

23 Sep 2010

Nerve inflammation may cause postsurgical neuropathies: Study

A new Mayo Clinic study found that nerve inflammation may cause the pain, numbness and weakness following surgical procedures that is known as postsurgical neuropathy. The development of postsurgical neuropathies is typically attributed to compression or stretching of nerves during surgery. This new research shows that, in some cases, the neuropathy is actually caused by the immune system attacking the nerves and is potentially treatable with immunosuppressive drugs.

23 Sep 2010

Cardiovascular Innovation Institute awarded NIH grant to develop implantable pump for single ventricle heart disease

Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.

23 Sep 2010

DCGI approves ADXS11-001 human testing for cervix cancer

As part of approving the human testing of ADXS11-001 the lead agent for the treatment of cervix cancer of Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company the Drugs Controller General of India (DCGI) required that the agent be tested to assure its safety prior to use.

23 Sep 2010

Aeras Global TB Vaccine Foundation to initiate clinical trial of new investigational vaccine

At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be led by researchers at Saint Louis University in St. Louis, Missouri, USA. The announcement was made at the Second Global Forum on TB Vaccine Development.

23 Sep 2010

Federal officials seek stronger workforce safety standards for health workers

Scripps Howard News Service/The (Montgomery County, Pa.) Times Herald: "Federal officials of the Occupational Safety and Health Administration announced this month they will consider proposals from advocacy, labor and student groups that contend work-hour rules proposed by an accreditation council's task force don't go far enough. They're pushing for new caps [on how long medical residents can work] including: No more than 80 hours in any week, compared to current standards that allow for an average of 80 hours.

23 Sep 2010

Biogen Idec concurs with FDA on safety monitoring for Gilenya through REMS

Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality.

23 Sep 2010

Scientists develop humanized mouse model to study typhoid fever

Better treatments and prevention for typhoid fever may emerge from a laboratory model that has just been developed for the disease. The model is based on transplanting human immune stem cells from umbilical cord blood into mice that are susceptible to infections.

23 Sep 2010

DSMB authorizes Oxygen Biotherapeutics' next cohort of Oxycyte emulsion study in severe non-penetrating TBI

Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.

23 Sep 2010

Researchers develop drug to eliminate disease transmission by cough

What if there was a drug that could completely eliminate airborne disease transmission that occurs when someone coughs. Researchers at the University of Alberta believe they have found a way to achieve this.

23 Sep 2010

Medical News

Dr. Reddy's Laboratories files Annual Report on Form 20-F

Covidien launches Puritan Bennett 560 ventilator in Europe

FDA approves fingolimod drug for multiple sclerosis

Masonic Cancer Center receives five-year program project research grants from NCI

Scientists identify genetic variants that increase asthma susceptibility

Portable laser devices to probe early signs of diseases

People's Care ranks #2140 on Inc. 5000 list of fastest growing private companies

Genomic imprinting can influence carrier's selfish or altruistic behavior

Opinions: Genetically-modified crops can improve vaccines; MDG focus on women and girls; U.S. leadership for MDGs; Boosting access to drugs; Merits of bilateral development assistance

First intestine transplant in Michigan performed on 50-year-old Port Austin patient

CSI to present CALCIUM 360° Study results at TCT symposium

Nerve inflammation may cause postsurgical neuropathies: Study

Cardiovascular Innovation Institute awarded NIH grant to develop implantable pump for single ventricle heart disease

DCGI approves ADXS11-001 human testing for cervix cancer

Aeras Global TB Vaccine Foundation to initiate clinical trial of new investigational vaccine

Federal officials seek stronger workforce safety standards for health workers

Biogen Idec concurs with FDA on safety monitoring for Gilenya through REMS

Scientists develop humanized mouse model to study typhoid fever

DSMB authorizes Oxygen Biotherapeutics' next cohort of Oxycyte emulsion study in severe non-penetrating TBI

Researchers develop drug to eliminate disease transmission by cough

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News